Luc Van Rompaey
Ablynx (Belgium)(BE)KU Leuven(BE)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Lymphoma Diagnosis and Treatment, Cytokine Signaling Pathways and Interactions, Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research
Most-Cited Works
- → Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia(1997)481 cited
- → Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes(1998)250 cited
- → Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases(2013)229 cited
- → Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents(2020)204 cited
- → Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634(2014)118 cited
- → The MN1-TEL Fusion Protein, Encoded by the Translocation (12;22)(p13;q11) in Myeloid Leukemia, Is a Transcription Factor with Transforming Activity(2000)95 cited